Suppr超能文献

呼吸道肠道病毒(如副流感病毒)如果失去气道上皮 STAT1 的保护,可导致慢性肺病。

Respiratory Enterovirus (like Parainfluenza Virus) Can Cause Chronic Lung Disease if Protection by Airway Epithelial STAT1 Is Lost.

机构信息

Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO 63110.

Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO 63110

出版信息

J Immunol. 2019 Apr 15;202(8):2332-2347. doi: 10.4049/jimmunol.1801491. Epub 2019 Feb 25.

Abstract

Epithelial barrier cells are proposed to be critical for host defense, and airway epithelial cell capacity for IFN signal transduction is presumed to protect against respiratory viral infection. However, it has been difficult to fully test these concepts given the absence of tools to analyze IFN signaling specific to airway epithelial cells in vivo. To address these issues, we generated a new line of transgenic mice with -driver genes ( and ) for a floxed- allele (designated mice) to target the master IFN signal regulator STAT1 in airway epithelial cells and tested these mice for control of infection because of mouse parainfluenza (Sendai) virus and human enterovirus D68 (EV-D68). Indeed, both types of infections showed increases in viral titers and severity of acute illness in mice and conventional mice compared with wild-type mice. In concert, the chronic lung disease that develops after Sendai virus infection was also increased in and mice, marked by airway and adjacent parenchymal immune cell infiltration and mucus production for at least 7 wk postinfection. Unexpectedly, relatively mild EV-D68 infection also progressed to chronic lung disease in and mice but was limited (like viral replication) to airways. The results thereby provide proof-of-concept for a critical role of barrier epithelial cells in protection from acute illness and chronic disease after viral infection and suggest a specific role for airway epithelial cells given the limitation of EV-D68 replication and acute and chronic manifestations of disease primarily to airway tissue.

摘要

上皮屏障细胞被认为对宿主防御至关重要,气道上皮细胞进行 IFN 信号转导的能力被认为可以防止呼吸道病毒感染。然而,由于缺乏在体内分析气道上皮细胞中 IFN 信号的特定工具,这些概念很难得到充分验证。为了解决这些问题,我们生成了一种新的转基因小鼠系,带有 -驱动基因(和)的 -基因(和)的 floxed-等位基因(命名为 小鼠),以在气道上皮细胞中靶向主要 IFN 信号调节剂 STAT1,并测试了这些小鼠对感染的控制作用,因为它们感染了小鼠副流感病毒(仙台病毒)和人类肠道病毒 D68(EV-D68)。事实上,与野生型小鼠相比,这两种类型的感染都导致了 小鼠和常规 小鼠中病毒滴度和急性疾病严重程度的增加。同时,仙台病毒感染后发生的慢性肺部疾病在 和 小鼠中也增加了,其特征是气道和相邻实质免疫细胞浸润以及粘液产生,至少持续 7 周。出乎意料的是,相对轻微的 EV-D68 感染也会导致 和 小鼠发生慢性肺部疾病,但仅限于气道(类似于病毒复制)。结果为此提供了上皮屏障细胞在病毒感染后预防急性疾病和慢性疾病的关键作用的概念验证,并表明气道上皮细胞具有特定的作用,因为 EV-D68 复制以及疾病的急性和慢性表现主要局限于气道组织。

相似文献

1
Respiratory Enterovirus (like Parainfluenza Virus) Can Cause Chronic Lung Disease if Protection by Airway Epithelial STAT1 Is Lost.
J Immunol. 2019 Apr 15;202(8):2332-2347. doi: 10.4049/jimmunol.1801491. Epub 2019 Feb 25.
2
3
TREM-2 promotes macrophage survival and lung disease after respiratory viral infection.
J Exp Med. 2015 May 4;212(5):681-97. doi: 10.1084/jem.20141732. Epub 2015 Apr 20.
7
Cytokine-independent upregulation of MDA5 in viral infection.
J Virol. 2007 Jul;81(13):7316-9. doi: 10.1128/JVI.00545-07. Epub 2007 May 2.
9
Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment.
Virus Res. 2006 Oct;121(1):23-32. doi: 10.1016/j.virusres.2006.03.012. Epub 2006 May 3.

引用本文的文献

1
O-GlcNAc transferase plays dual antiviral roles by integrating innate immunity and lipid metabolism.
Nat Commun. 2025 Aug 19;16(1):7721. doi: 10.1038/s41467-025-63085-y.
2
Murine parainfluenza virus persists in lung innate immune cells sustaining chronic lung pathology.
Nat Microbiol. 2024 Nov;9(11):2803-2816. doi: 10.1038/s41564-024-01805-8. Epub 2024 Oct 2.
3
The post-viral GPNMB immune niche persists in long-term Covid, asthma, and COPD.
medRxiv. 2024 Aug 28:2024.08.27.24312640. doi: 10.1101/2024.08.27.24312640.
4
A first-in-kind MAPK13 inhibitor that can correct stem cell reprogramming and post-injury disease.
bioRxiv. 2024 Aug 22:2024.08.21.608990. doi: 10.1101/2024.08.21.608990.
5
A correctable immune niche for epithelial stem cell reprogramming and post-viral lung diseases.
J Clin Invest. 2024 Jul 25;134(18):e183092. doi: 10.1172/JCI183092.
7
MAPK13 controls structural remodeling and disease after epithelial injury.
bioRxiv. 2024 Aug 10:2024.05.31.596863. doi: 10.1101/2024.05.31.596863.
8
Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease.
Eur Respir Rev. 2024 Feb 28;33(171). doi: 10.1183/16000617.0220-2023. Print 2024 Jan 31.
10
Murine Parainfluenza Virus Persists in Lung Innate Immune Cells Sustaining Chronic Lung Pathology.
bioRxiv. 2023 Nov 8:2023.11.07.566103. doi: 10.1101/2023.11.07.566103.

本文引用的文献

1
Development of a respiratory disease model for enterovirus D68 in 4-week-old mice for evaluation of antiviral therapies.
Antiviral Res. 2019 Feb;162:61-70. doi: 10.1016/j.antiviral.2018.11.012. Epub 2018 Dec 3.
2
Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice.
Virology. 2019 Jan 2;526:146-154. doi: 10.1016/j.virol.2018.10.014. Epub 2018 Oct 31.
3
Influenza A Virus Infection Causes Chronic Lung Disease Linked to Sites of Active Viral RNA Remnants.
J Immunol. 2018 Oct 15;201(8):2354-2368. doi: 10.4049/jimmunol.1800671. Epub 2018 Sep 12.
5
Biologics and chronic obstructive pulmonary disease.
J Allergy Clin Immunol. 2018 Jun;141(6):1983-1991. doi: 10.1016/j.jaci.2018.04.020. Epub 2018 May 4.
6
STAT1 Is Required for Suppression of Type 17 Immunity during Influenza and Bacterial Superinfection.
Immunohorizons. 2017 Aug 1;1(6):81-91. doi: 10.4049/immunohorizons.1700030.
7
Cytokine-targeting biologics for allergic diseases.
Ann Allergy Asthma Immunol. 2018 Apr;120(4):376-381. doi: 10.1016/j.anai.2018.01.009. Epub 2018 Feb 2.
8
Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction.
J Clin Invest. 2018 Mar 1;128(3):997-1009. doi: 10.1172/JCI95693. Epub 2018 Feb 5.
10
ImageJ2: ImageJ for the next generation of scientific image data.
BMC Bioinformatics. 2017 Nov 29;18(1):529. doi: 10.1186/s12859-017-1934-z.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验